Watch for Andexxa, a New Reversal Agent to Treat Anticoagulant-Related Bleeds

You’ll hear about a new, IV direct oral anticoagulant (DOAC) reversal agent called Andexxa (an-DEK-sah, inactivated recombinant factor Xa)...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login